Literature DB >> 31076509

Formation of mammalian preribosomes proceeds from intermediate to composed state during ribosome maturation.

Danysh A Abetov1, Vladimir S Kiyan1, Assylbek A Zhylkibayev1, Dilara A Sarbassova1, Sanzhar D Alybayev1, Eric Spooner2, Min Sup Song1,3, Rakhmetkazhy I Bersimbaev4, Dos D Sarbassov5,3,6.   

Abstract

In eukaryotes, ribosome assembly is a rate-limiting step in ribosomal biogenesis that takes place in a distinctive subnuclear organelle, the nucleolus. How ribosomes get assembled at the nucleolar site by forming initial preribosomal complexes remains poorly characterized. In this study, using several human and murine cell lines, we developed a method for isolation of native mammalian preribosomal complexes by lysing cell nuclei through mild sonication. A sucrose gradient fractionation of the nuclear lysate resolved several ribonucleoprotein (RNP) complexes containing rRNAs and ribosomal proteins. Characterization of the RNP complexes with MS-based protein identification and Northern blotting-based rRNA detection approaches identified two types of preribosomes we named here as intermediate preribosomes (IPRibs) and composed preribosome (CPRib). IPRib complexes comprised large preribosomes (105S to 125S in size) containing the rRNA modification factors and premature rRNAs. We further observed that a distinctive CPRib complex consists of an 85S preribosome assembled with mature rRNAs and a ribosomal biogenesis factor, Ly1 antibody-reactive (LYAR), that does not associate with premature rRNAs and rRNA modification factors. rRNA-labeling experiments uncovered that IPRib assembly precedes CPRib complex formation. We also found that formation of the preribosomal complexes is nutrient-dependent because the abundances of IPRib and CPRib decreased substantially when cells were either deprived of amino acids or exposed to an mTOR kinase inhibitor. These findings indicate that preribosomes form via dynamic and nutrient-dependent processing events and progress from an intermediate to a composed state during ribosome maturation.
© 2019 Abetov et al.

Entities:  

Keywords:  gradient fractionation; mammalian target of rapamycin (mTOR); pre-ribosomal complexes; precursor ribosomal RNA (pre-rRNA); rRNA processing; ribosomal RNA processing (rRNA processing); ribosomal biogenesis factors; ribosomal proteins; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); subcellular fractionation

Mesh:

Substances:

Year:  2019        PMID: 31076509      PMCID: PMC6635442          DOI: 10.1074/jbc.AC119.008378

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Ribosomal precursor particles from yeast.

Authors:  J Trapman; J Retèl; R J Planta
Journal:  Exp Cell Res       Date:  1975-01       Impact factor: 3.905

Review 2.  Pre-ribosomes on the road from the nucleolus to the cytoplasm.

Authors:  Herbert Tschochner; Ed Hurt
Journal:  Trends Cell Biol       Date:  2003-05       Impact factor: 20.808

3.  90S pre-ribosomes include the 35S pre-rRNA, the U3 snoRNP, and 40S subunit processing factors but predominantly lack 60S synthesis factors.

Authors:  Paola Grandi; Vladimir Rybin; Jochen Bassler; Elisabeth Petfalski; Daniela Strauss; Martina Marzioch; Thorsten Schäfer; Bernhard Kuster; Herbert Tschochner; David Tollervey; Anne Claude Gavin; Ed Hurt
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

Review 4.  Ribosomal RNA processing and ribosome biogenesis in eukaryotes.

Authors:  Ross N Nazar
Journal:  IUBMB Life       Date:  2004-08       Impact factor: 3.885

5.  Nucleolar proteome dynamics.

Authors:  Jens S Andersen; Yun W Lam; Anthony K L Leung; Shao-En Ong; Carol E Lyon; Angus I Lamond; Matthias Mann
Journal:  Nature       Date:  2005-01-06       Impact factor: 49.962

6.  Phosphatidylinositol 3-kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients.

Authors:  Martyn J James; Joost C B M Zomerdijk
Journal:  J Biol Chem       Date:  2003-12-19       Impact factor: 5.157

7.  mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability.

Authors:  Christine Mayer; Jian Zhao; Xuejun Yuan; Ingrid Grummt
Journal:  Genes Dev       Date:  2004-02-15       Impact factor: 11.361

8.  Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome.

Authors:  Toshiya Hayano; Mitsuaki Yanagida; Yoshio Yamauchi; Takashi Shinkawa; Toshiaki Isobe; Nobuhiro Takahashi
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

9.  Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.

Authors:  Davide Ruggero; Silvia Grisendi; Francesco Piazza; Eduardo Rego; Francesca Mari; Pulivarthi H Rao; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

10.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

View more
  3 in total

1.  The young and the restless: Isolating the dynamic mammalian preribosomes.

Authors:  Estela Jacinto
Journal:  J Biol Chem       Date:  2019-07-12       Impact factor: 5.157

Review 2.  Regulation and metabolic functions of mTORC1 and mTORC2.

Authors:  Angelia Szwed; Eugene Kim; Estela Jacinto
Journal:  Physiol Rev       Date:  2021-02-18       Impact factor: 46.500

3.  LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism.

Authors:  Yupeng Wu; Yu Zhou; Haiying Gao; Yajun Wang; Qingyu Cheng; Shikun Jian; Qi Ding; Wei Gu; Yanxue Yao; Jia Ma; Wenjuan Wu; Yuyun Li; Xuhui Tong; Xiaoyuan Song; Sai Ma
Journal:  Oxid Med Cell Longev       Date:  2021-12-06       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.